Jane Street’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.3M | Buy |
115,850
+31,297
| +37% | +$4.23M | ﹤0.01% | 2230 |
|
|
2026
Q1 | $10.8M | Buy |
84,553
+77,998
| +1,190% | +$9.74M | ﹤0.01% | 2443 |
|
|
2025
Q4 | $799K | Sell |
6,555
-4,076
| -38% | -$467K | ﹤0.01% | 6615 |
|
|
2025
Q3 | $1.07M | Sell |
10,631
-1,265,458
| -99% | -$114M | ﹤0.01% | 6178 |
|
|
2025
Q2 | $106M | Sell |
1,276,089
-193,580
| -13% | -$15.4M | 0.02% | 445 |
|
|
2025
Q1 | $119M | Buy |
1,469,669
+153,853
| +12% | +$13.8M | 0.03% | 332 |
|
|
2024
Q4 | $119M | Buy |
1,315,816
+371,088
| +39% | +$36M | 0.03% | 376 |
|
|
2024
Q3 | $93.3M | Sell |
944,728
-48,299
| -5% | -$4.75M | 0.02% | 411 |
|
|
2024
Q2 | $92.1M | Buy |
993,027
+31,945
| +3% | +$2.86M | 0.02% | 429 |
|
|
2024
Q1 | $91.2M | Buy |
961,082
+391,333
| +69% | +$36.3M | 0.02% | 397 |
|
|
2023
Q4 | $50.9M | Sell |
569,749
-383,976
| -40% | -$28.5M | 0.01% | 666 |
|
|
2023
Q3 | $69.6M | Sell |
953,725
-924,610
| -49% | -$73.9M | 0.02% | 433 |
|
|
2023
Q2 | $156M | Buy |
1,878,335
+348,522
| +23% | +$29.1M | 0.05% | 218 |
|
|
2023
Q1 | $117M | Buy |
1,529,813
+1,161,234
| +315% | +$96.4M | 0.05% | 264 |
|
|
2022
Q4 | $30.6M | Buy |
368,579
+124,432
| +51% | +$10.1M | 0.01% | 748 |
|
|
2022
Q3 | $19.4M | Buy |
244,147
+71,417
| +41% | +$6.02M | 0.01% | 1096 |
|
|
2022
Q2 | $12.8M | Buy |
172,730
+100,982
| +141% | +$7.58M | 0.01% | 1479 |
|
|
2022
Q1 | $6.45M | Sell |
71,748
-2,437,127
| -97% | -$225M | ﹤0.01% | 2619 |
|
|
2021
Q4 | $281M | Buy |
2,508,875
+1,500,588
| +149% | +$181M | 0.09% | 126 |
|
|
2021
Q3 | $127M | Buy |
1,008,287
+823,149
| +445% | +$106M | 0.04% | 280 |
|
|
2021
Q2 | $25.1M | Sell |
185,138
-247,298
| -57% | -$32.5M | 0.01% | 916 |
|
|
2021
Q1 | $58.7M | Buy |
432,436
+388,419
| +882% | +$58.2M | 0.03% | 433 |
|
|
2020
Q4 | $6.2M | Buy |
44,017
+36,546
| +489% | +$4.68M | ﹤0.01% | 1873 |
|
|
2020
Q3 | $832K | Buy |
7,471
+1,850
| +33% | +$207K | ﹤0.01% | 4399 |
|
|
2020
Q2 | $629K | Sell |
5,621
-186,479
| -97% | -$18.4M | ﹤0.01% | 4721 |
|
|
2020
Q1 | $14.9M | Buy |
192,100
+170,979
| +810% | +$15.1M | 0.01% | 565 |
|
|
2019
Q4 | $2.01M | Buy |
+21,121
| New | +$1.83M | ﹤0.01% | 1939 |
|
|
2019
Q2 | – | Sell |
-44,222
| Closed | -$3.77M | – | 5834 |
|
|
2019
Q1 | $4M | Sell |
44,222
-597,741
| -93% | -$50.9M | 0.01% | 1328 |
|
|
2018
Q4 | $46.1M | Buy |
641,963
+620,457
| +2,885% | +$50M | 0.1% | 147 |
|
|
2018
Q3 | $2.06M | Buy |
+21,506
| New | +$2.09M | ﹤0.01% | 1869 |
|
|
2018
Q2 | – | Sell |
-129,150
| Closed | -$11.9M | – | 5715 |
|
|
2018
Q1 | $11.3M | Sell |
129,150
-138,086
| -52% | -$12.6M | 0.03% | 484 |
|
|
2017
Q4 | $22.7M | Buy |
+267,236
| New | +$22.4M | 0.07% | 269 |
|
|
2017
Q3 | – | Sell |
-4,283
| Closed | -$343K | – | 5165 |
|
|
2017
Q2 | $331K | Sell |
4,283
-68,319
| -94% | -$4.85M | ﹤0.01% | 3500 |
|
|
2017
Q1 | $5.03M | Buy |
72,602
+44,083
| +155% | +$2.96M | 0.02% | 703 |
|
|
2016
Q4 | $1.69M | Sell |
28,519
-6,372
| -18% | -$393K | 0.01% | 1475 |
|
|
2016
Q3 | $2.31M | Sell |
34,891
-129,471
| -79% | -$8.01M | 0.01% | 1083 |
|
|
2016
Q2 | $8.89M | Buy |
+164,362
| New | +$9.01M | 0.04% | 376 |
|
|
2016
Q1 | – | Sell |
-30,959
| Closed | -$1.61M | – | 4721 |
|
|
2015
Q4 | $2.17M | Sell |
30,959
-262,590
| -89% | -$17.9M | 0.01% | 994 |
|
|
2015
Q3 | $18.3M | Buy |
+293,549
| New | +$23.1M | 0.11% | 146 |
|
|
2015
Q2 | – | Sell |
-64,416
| Closed | -$5.01M | – | 4115 |
|
|
2015
Q1 | $4.84M | Buy |
+64,416
| New | +$4.5M | 0.04% | 413 |
|
|
2014
Q4 | – | Sell |
-6,072
| Closed | -$346K | – | 3109 |
|
|
2014
Q3 | $316K | Sell |
6,072
-52,488
| -90% | -$2.68M | ﹤0.01% | 1843 |
|
|
2014
Q2 | $3.01M | Buy |
+58,560
| New | +$2.64M | 0.04% | 394 |
|
|
2013
Q4 | – | Sell |
-11,175
| Closed | -$481K | – | 2965 |
|
|
2013
Q3 | $481K | Buy |
+11,175
| New | +$453K | 0.01% | 1742 |
|
Other funds holding XBI
JFG
Jane Street's XBI Position: Q2 2026 in Review
Jane Street increased its State Street SPDR S&P Biotech ETF (XBI) stake by 37% in Q2 2026, buying an estimated $4.23M and bringing the position to 115,850 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2230.
Jane Street first reported a position in XBI in Q3 2013 and has held it in 43 quarters since. The position peaked at $281M in Q4 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Jane Street held 115,850 shares of State Street SPDR S&P Biotech ETF worth $18.3M as of Q2 2026.
- Jane Street bought 31,297 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $4.23M.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2230 holding.
- Jane Street first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and has held it in 43 quarters since.
- Jane Street's State Street SPDR S&P Biotech ETF position peaked at $281M in Q4 2021.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.